The measurement of CSF α-synuclein in combination with FMS-like tyrosine kinase 3 ligand (FLT3L) or the percentage phosphorylated tau (p-tau) clearly distinguished PD from MSA in a study (Shi et al., 2011). This evidence concerns the gene MAPT and multiple system atrophy.